Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

34 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-10-31

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chorioamnionitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women giving birth week 37-42
* healthy
* one fetus

Exclusion Criteria

* more than one fetus
* IUGR
* illness or damage to fetus

Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Mankuta, MD

Role: STUDY_CHAIR

Hadassah Medical Organization

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haddasah Medical Organization

Jerusalem, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

david mankuta, MD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David Mankuta

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MCA chorioamnionitis HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id